Navigation Links
New American Therapeutics Acquires Antiviral Drug Denavir®
Date:10/3/2010

CRANFORD, N.J., Oct. 4 /PRNewswire/ -- New American Therapeutics, Inc., announced today that it acquired all U.S. rights to manufacture, market and sell the antiviral topical drug Denavir® owned by Novartis.  Denavir (1% penciclovir cream) is a highly selective and potent topical antiviral treatment indicated for the treatment of recurrent herpes labialis (cold sores) in adults and children 12 years of age and older.  The topical antiviral cream market in the U.S. is valued at approximately $100 million annually.

Novartis has agreed to provide limited transitional services to New American Therapeutics to allow for a smooth transition of the business to New American Therapeutics.  

"Denavir offers patients a proven therapy for the treatment of herpes labialis.  Likewise, the established revenue stream will provide New American Therapeutics with the capital required to expand our growing infrastructure and product line," stated Alan L. Rubino, CEO and President of New American Therapeutics.  "We are enthusiastic about advancing the commercial efforts of this important asset."

Denavir 1% penciclovir topical cream is a safe and effective medicine when used as directed. Patients should read the package directions before using Denavir.  Possible side effects include headache or irritation at the site of application. Patients should contact their doctor if they experience these symptoms as a result of using Denavir.  Patients should consult their doctor before using 1% penciclovir topical cream if they are allergic to penciclovir or acyclovir (Zovirax®), or any other drugs, or are pregnant or nursing.

About New American Therapeutics, Inc.New American Therapeutics, Inc. is a privately held, specialty pharmaceutical company based in Cranford, N.J. that acquires, markets and develops products in select therapeutic areas.CONTACT:

Alan L. Rubino  908-372-8108Email: arubino@natxcorp.com
'/>"/>

SOURCE New American Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. United American Healthcare Corporation Announces Results of Annual Meeting of Shareholders
2. WellSpring Pharmaceutical, American Gastroenterological Association, and Steven Bramson of Humanscale Partner With MediaPlanet to Publish One of the Largest Digestive Wellness Campaigns in U.S. History to Overcome Upset Stomach, Nausea, IBS, and Deb
3. CVS Caremark Recognizes Its 26,000 Pharmacists During Octobers American Pharmacists Month
4. Idenix Announces Data Presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
5. American College of Surgeons Clinical Congress Convenes in Washington, DC, October 3-7, 2010
6. Millions of Americans Are Living With Hidden Epidemics of Hepatitis B and C, Top Experts Warn
7. Lexiscan® (Regadenoson) Injection Study in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD) Presented as Late-Breaker at American Society of Nuclear Cardiology 2010
8. American Society of Tropical Medicine and Hygiene (ASTMH) Calls for Stronger FDA Science Investment to Better Fight Diseases of Poverty Worldwide
9. Latin American Aortic Stent Graft Market to Reach Over $150 Million by 2015, According to Millennium Research Group
10. American Pacific Adopts Corporate Governance Changes
11. North American Spine Welcomes Kenneth Alo, M.D. to Physician Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... , Dec. 9, 2016  RxWiki Inc., a digital ... digital marketing strategies of thousands of pharmacies through its ... Austin Inno,s "50 on Fire" Award in ... "We,re pleased to accept the award as one of ... Chief Executive Officer at RxWiki. "Our platform gives independent ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
(Date:12/8/2016)... , Dec. 8, 2016 Global Interventional ... on the global interventional radiology market analyzes the ... report comprises an elaborate executive summary, including a ... segments and sub-segments. The research is a ... formed the bulk of our research efforts along ...
Breaking Medicine Technology:
(Date:12/9/2016)... - Cincinnati, Ohio (PRWEB) , ... December 09, ... ... the production of miniature, folded, pharmaceutical inserts and outserts. As a means ... Device. This addition will enable Flottman to individually code professional inserts (PIs) ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted to fulfill ... of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It ... could be set up in a matter of minutes, or even seconds. The SAFETY ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced the promotions ... Eric Hoessel to vice president of sales. , Litsinger joined Mirixa in ...
Breaking Medicine News(10 mins):